Helmholtz Gemeinschaft

Search
Browse
Statistics
Feeds

Browse by Research Team

Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Date | Item Type | Source
Jump to: 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2003 | 2002 | 2001

2018

A comparative analysis of human bone marrow-resident and peripheral memory B cells.
Becker, S.C. and Szyska, M. and Mensen, A. and Hellwig, K. and Otto, R. and Olfe, L. and Volk, H.D. and Dörner, T. and Dörken, B. and Scheibenbogen, C. and Schröder, J. and Hocke, A.C. and Na, I.K.
Journal of Allergy and Clinical Immunology 141 (5): 1911-1913. May 2018

Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells.
Hammer, Q. and Rückert, T. and Borst, E.M. and Dunst, J. and Haubner, A. and Durek, P. and Heinrich, F. and Gasparoni, G. and Babic, M. and Tomic, A. and Pietra, G. and Nienen, M. and Blau, I.W. and Hofmann, J. and Na, I.K. and Prinz, I. and Koenecke, C. and Hemmati, P. and Babel, N. and Arnold, R. and Walter, J. and Thurley, K. and Mashreghi, M.F. and Messerle, M. and Romagnani, C.
Nature Immunology 19 (5): 453-463. May 2018

A transgenic dual-luciferase reporter mouse for longitudinal and functional monitoring of T cells in vivo.
Szyska, M. and Herda, S. and Althoff, S. and Heimann, A. and Russ, J. and D'Abundo, D. and Dang, T.M. and Durieux, I. and Dörken, B. and Blankenstein, T. and Na, I.K.
Cancer Immunology Research 6 (1): 110-120. January 2018

2017

Predictive significance of the European LeukemiaNet classification of genetic aberrations in patients with acute myeloid leukemia undergoing allogeneic stem cell transplantation.
Hemmati, P.G. and Vuong, L.G. and Terwey, T.H. and Jehn, C.F. and Le Coutre, P. and Penack, O. and Na, I.K. and Dörken, B. and Arnold, R.
European Journal of Haematology 98 (2): 160-168. February 2017

2016

Bone marrow GvHD after allogeneic hematopoietic stem cell transplantation.
Szyska, M. and Na, I.K.
Frontiers in Immunology 7 : 118. 30 March 2016

2015

Allogeneic stem cell transplantation for refractory acute myeloid leukemia: a single center analysis of long-term outcome.
Hemmati, P.G. and Terwey, T.H. and Na, I.K. and Jehn, C.F. and le Coutre, P. and Vuong, L.G. and Doerken, B. and Arnold, R.
European Journal of Haematology 95 (6): 498-506. December 2015

Altered B-cell subsets and functional B-cell defects in selective IgM deficiency.
Mensen, A. and Krause, T. and Hanitsch, L.G. and Meisel, C. and Kleint, M.E. and Volk, H.D. and Na, I.K. and Scheibenbogen, C.
Clinical Immunology 161 (2): 96-102. December 2015

Apoptosis-susceptibility prolongs the lack of memory B cells in acute leukemic patients after allogeneic hematopoietic stem cell transplantation.
Mensen, A. and Oh, Y. and Becker, S.C. and Hemmati, P.G. and Jehn, C. and Westermann, J. and Szyska, M. and Göldner, H. and Dörken, B. and Scheibenbogen, C. and Arnold, R. and Na, I.K.
Biology of Blood and Marrow Transplantation 21 (11): 1895-1906. November 2015

Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multi-center survey.
Zeiser, R. and Burchert, A. and Lengerke, C. and Verbeek, M. and Maas-Bauer, K. and Metzelder, S.K. and Spoerl, S. and Ditschkowski, M. and Ecsedi, M. and Sockel, K. and Ayuk, F. and Ajib, S. and de Fontbrune, F.S. and Na, I.K. and Penter, L. and Holtick, U. and Wolf, D. and Schuler, E. and Meyer, E. and Apostolova, P. and Bertz, H. and Marks, R. and Lübbert, M. and Wäsch, R. and Scheid, C. and Stölzel, F. and Ordemann, R. and Bug, G. and Kobbe, G. and Negrin, R. and Brune, M. and Spyridonidis, A. and Schmitt-Gräff, A. and van der Velden, W. and Huls, G. and Mielke, S. and Grigoleit, G.U. and Kuball, J. and Flynn, R. and Ihorst, G. and Du, J. and Blazar, B.R. and Arnold, R. and Kröger, N. and Passweg, J. and Halter, J. and Socie, G. and Beelen, D. and Peschel, C. and Neubauer, A. and Finke, J. and Duyster, J. and von Bubnoff, N.
Leukemia 29 (10): 2062-2068. October 2015

Emerging role of tyrosine kinases as drugable targets in cancer.
Na, I.K. and Le Coutre, P.
Biomarker Insights 10 (S3): 29-31. 10 September 2015

Impact of early remission by induction therapy on allogeneic stem cell transplantation for acute myeloid leukemia with an intermediate risk karyotype in first complete remission.
Hemmati, P.G. and Terwey, T.H. and Na, I.K. and le Coutre, P. and Jehn, C.F. and Vuong, L.G. and Dörken, B. and Arnold, R.
European Journal of Haematology 94 (5): 431-438. May 2015

2014

Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.
Mensen, A. and Na, I.K. and Häfer, R. and Meerbach, A. and Schlecht, M. and Pietschmann, M.L. and Gruhn, B.
Journal of Cancer Research and Clinical Oncology 140 (11): 1971-1980. November 2014

Bone marrow T-cell infiltration during acute GVHD is associated with delayed B-cell recovery and function after HSCT.
Mensen, A. and Jöhrens, K. and Anagnostopoulos, I. and Demski, S. and Oey, M. and Stroux, A. and Hemmati, P. and Westermann, J. and Blau, O. and Wittenbecher, F. and Movassaghi, K. and Szyska, M. and Thomas, S. and Dörken, B. and Scheibenbogen, C. and Arnold, R. and Na, I.K.
Blood 124 (6): 963-972. 7 August 2014

2013

Rabbit antithymocyte globulin induces rapid expansion of effector memory CD8 T cells without accelerating acute graft versus host disease.
Wittenbecher, F. and Rieger, K. and Dziubianau, M. and Herholz, A. and Mensen, A. and Blau, I.W. and Uharek, L. and Dörken, B. and Thiel, A. and Na, I.K.
Leukemia Research Reports 2 (2): 82-85. 27 September 2013

Utilization of TREC and KREC quantification for the monitoring of early T- and B-cell neogenesis in adult patients after allogeneic hematopoietic stem cell transplantation.
Mensen, A. and Ochs, C. and Stroux, A. and Wittenbecher, F. and Szyska, M. and Imberti, L. and Fillatreau, S. and Uharek, L. and Arnold, R. and Dörken, B. and Thiel, A. and Scheibenbogen, C. and Na, I.K.
Journal of Translational Medicine 11 (1): 188. 14 August 2013

PLZF confers effector functions to donor T cells that preserve graft-versus-tumor effects while attenuating graft-versus-host-disease.
Ghosh, A. and Holland, A.M. and Dogan, Y. and Yim, N. and Rao, U.K. and Young, L.F. and West, M.L. and Singer, N.V. and Lee, H. and Na, I.K. and Tsai, J.J. and Jenq, R. and Penack, O. and Hanash, A.M. and Lezcano, C. and Murphy, G.F. and Liu, C. and Sadelain, M. and Sauer, M.G. and Sant'Angelo, D. and van den Brink, M.R.M.
Cancer Research 73 (15): 4687-4696. 1 August 2013

Rabbit antithymocyte globulin (Thymoglobulin(R)) impairs the thymic output of both conventional and regulatory CD4(+) T cells after allogeneic hematopoietic stem cell transplantation in adult patients.
Na, I.K. and Wittenbecher, F. and Dziubianau, M. and Herholz, A. and Mensen, A. and Kunkel, D. and Blau, O. and Blau, I. and Thiel, E. and Uharek, L. and Scheibenbogen, C. and Rieger, K. and Thiel, A.
Haematologica 98 (1): 23-30. January 2013

2011

Abrogation of donor T-cell IL-21 signaling leads to tissue-specific modulation of immunity and separation of GVHD from GVL.
Hanash, A.M. and Kappel, L.W. and Yim, N.L. and Nejat, R.A. and Goldberg, G.L. and Smith, O.M. and Rao, U.K. and Dykstra, L. and Na, I.K. and Holland, A.M. and Dudakov, J.A. and Liu, C. and Murphy, G.F. and Leonard, W.J. and Heller, G. and van den Brink, M.R.M.
Blood 118 (2): 446-455. 14 July 2011

Ceacam1 separates graft-versus-host-disease from graft-versus-tumor activity after experimental allogeneic bone marrow transplantation.
Lu, S.X. and Kappel, L.W. and Charbonneau-Allard, A.M. and Atallah, R. and Holland, A.M. and Turbide, C. and Hubbard, V.M. and Rotolo, J.A. and Smith, M. and Suh, D. and King, C. and Rao, U.K. and Yim, N. and Bautista, J.L. and Jenq, R.R. and Penack, O. and Na, I.K. and Liu, C. and Murphy, G. and Alpdogan, O. and Blumberg, R.S. and Macian, F. and Holmes, K.V. and Beauchemin, N. and van den Brink, M.R.M.
PLoS ONE 6 (7): e21611. 6 July 2011

2010

Concurrent visualization of trafficking, expansion, and activation of T lymphocytes and T-cell precursors in vivo.
Na, I.K. and Markley, J.C. and Tsai, J.J. and Yim, N.L. and Beattie, B.J. and Klose, A.D. and Holland, A.M. and Ghosh, A. and Rao, U.K. and Stephan, M.T. and Serganova, I. and Santos, E.B. and Brentjens, R.J. and Blasberg, R.G. and Sadelain, M. and van den Brink, M.R.M.
Blood 116 (11): e18-e25. 16 September 2010

Absence of P-selectin in recipients of allogeneic bone marrow transplantation ameliorates experimental graft-versus-host disease.
Lu, S.X. and Holland, A.M. and Na, I.K. and Terwey, T.H. and Alpdogan, O. and Bautista, J.L. and Smith, O.M. and Suh, D. and King, C. and Kochman, A. and Hubbard, V.M. and Rao, U.K. and Yim, N. and Liu, C. and Laga, A.C. and Murphy, G. and Jenq, R.R. and Zakrzewski, J.L. and Penack, O. and Dykstra, L. and Bampoe, K. and Perez, L. and Furie, B. and Furie, B. and van den Brink, M.R.M.
Journal of Immunology 185 (3): 1912-1919. 1 August 2010

Inhibition of neovascularization to simultaneously ameliorate graft-vs-host disease and decrease tumor growth.
Penack, O. and Henke, E. and Suh, D. and King, C.G. and Smith, O.M. and Na, I.K. and Holland, A.M. and Ghosh, A. and Lu, S.X. and Jenq, R.R. and Liu, C. and Murphy, G.F. and Lu, T.T. and May, C. and Scheinberg, D.A. and Gao, D.C. and Mittal, V. and Heller, G. and Benezra, R. and van den Brink, M.R.M.
Journal of the National Cancer Institute 102 (12): 894-908. 16 June 2010

Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
Guerreiro, M. and Na, I.K. and Letsch, A. and Haase, D. and Bauer, S. and Meisel, C. and Roemhild, A. and Reinke, P. and Volk, H.D. and Scheibenbogen, C.
European Journal of Immunology 40 (6): 1566-1576. June 2010

The cytolytic molecules Fas ligand and TRAIL are required for murine thymic graft-versus-host disease.
Na, I.K. and Lu, S.X. and Yim, N.L. and Goldberg, G.L. and Tsai, J. and Rao, U. and Smith, O.M. and King, C.G. and Suh, D. and Hirschhorn-Cymerman, D. and Palomba, L. and Penack, O. and Holland, A.M. and Jenq, R.R. and Ghosh, A. and Tran, H. and Merghoub, T. and Liu, C. and Sempowski, G.D. and Ventevogel, M. and Beauchemin, N. and van den Brink, M.R.M.
Journal of Clinical Investigation 120 (1): 343-356. January 2010

2009

Human bone marrow as a source to generate CMV-specific CD4+ T cells with multifunctional capacity.
Na, I.K. and Letsch, A. and Guerreiro, M. and Bauer, S. and Noack, I. and Geginat, J. and Reinke, P. and Loesch, M. and Kienapfel, H. and Thiel, E. and Volk, H.D. and Scheibenbogen, C.
Journal of Immunotherapy 32 (9): 907-913. November 2009

NOD2 regulates hematopoietic cell function during graft-versus-host disease.
Penack, O. and Smith, O.M. and Cunningham-Bussel, A. and Liu, X. and Rao, U. and Yim, N. and Na, I.K. and Holland, A.M. and Ghosh, A. and Lu, S.X. and Jenq, R.R. and Liu, C. and Murphy, G.F. and Brandl, K. and van den Brink, M.R.M.
Journal of Experimental Medicine 206 (10): 2101-2110. 28 September 2009

Keratinocyte growth factor enhances DNA plasmid tumor vaccine responses after murine allogeneic bone marrow transplantation.
Jenq, R.R. and King, C.G. and Volk, C. and Suh, D. and Smith, O.M. and Rao, U.K. and Yim, N.L. and Holland, A.M. and Lu, S.X. and Zakrzewski, J.L. and Goldberg, G.L. and Diab, A. and Alpdogan, O. and Penack, O. and Na, I.K. and Kappel, L.W. and Wolchok, J.D. and Houghton, A.N. and Perales, M.A. and van den Brink, M.R.M.
Blood 113 (7): 1574-1580. 12 February 2009

2008

Nuclear expression of CXCR4 in tumor cells of non-small cell lung cancer is correlated with lymph node metastasis.
Na, I.K. and Scheibenbogen, C. and Adam, C. and Stroux, A. and Ghadjar, P. and Thiel, E. and Keilholz, U. and Coupland, S.E.
Human Pathology 39 (12): 1751-1755. December 2008

Identification of truncated chemokine receptor 7 in human colorectal cancer unable to localize to the cell surface and unreactive to external ligands.
Na, I.K. and Busse, A. and Scheibenbogen, C. and Ghadjar, P. and Coupland, S.E. and Letsch, A. and Loddenkemper, C. and Stroux, A. and Bauer, S. and Thiel, E. and Keilholz, U.
International Journal of Cancer 123 (7): 1565-1572. 1 October 2008

Sensitivity of tumor cells to proteasome inhibitors is associated with expression levels and composition of proteasome subunits.
Busse, A. and Kraus, M. and Na, I.K. and Rietz, A. and Scheibenbogen, C. and Driessen, C. and Blau, I.W. and Thiel, E. and Keilholz, U.
Cancer 112 (3): 659-670. 1 February 2008

2007

CMV-specific central memory T cells reside in bone marrow.
Letsch, A. and Knoedler, M. and Na, I.K. and Kern, F. and Asemissen, A.M. and Keilholz, U. and Loesch, M. and Thiel, E. and Volk, H.D. and Scheibenbogen, C.
European Journal of Immunology 37 (11): 3063-3068. November 2007

Addition of GM-CSF to a peptide/KLH vaccine results in increased frequencies of CXCR3-expressing KLH-specific T cells.
Na, I.K. and Keilholz, U. and Letsch, A. and Bauer, S. and Asemissen, A.M. and Nagorsen, D. and Thiel, E. and Scheibenbogen, C.
Cancer Immunology Immunotherapy 56 (3): 391-396. March 2007

2006

Developmental stage-specific shift in responsiveness to chemokines during human B-cell development.
Honczarenko, M. and Glodek, A.M. and Swierkowski, M. and Na, I.K. and Silberstein, L.E.
Experimental Hematology 34 (8): 1093-1100. August 2006

Chemokine receptor CCR6 expression level and liver metastases in colorectal cancer.
Ghadjar, P. and Coupland, S.E. and Na, I.K. and Noutsias, M. and Letsch, A. and Stroux, A. and Bauer, S. and Buhr, H.J. and Thiel, E. and Scheibenbogen, C. and Keilholz, U.
Journal of Clinical Oncology 24 (12): 1910-1916. 20 April 2006

Lymphomas are sensitive to perforin-dependent cytotoxic pathways despite expression of PI-9 and overexpression of bcl-2.
Godal, R. and Keilholz, U. and Uharek, L. and Letsch, A. and Asemissen, A.M. and Busse, A. and Na, I.K. and Thiel, E. and Scheibenbogen, C.
Blood 107 (8): 3205-3211. 15 April 2006

2005

Expression of the chemokine receptors CXCR4, CXCR5, and CCR7 in primary central nervous system lymphoma.
Jahnke, K. and Coupland, S.E. and Na, I.K. and Loddenkemper, C. and Keilholz, U. and Korfel, A. and Stein, H. and Thiel, E. and Scheibenbogen, C.
Blood 106 (1): 384-385. 1 July 2005

Imatinib mesylate radiosensitizes human glioblastoma cells through inhibition of platelet-derived growth factor receptor.
Holdhoff, M. and Kreuzer, K.A. and Appelt, C. and Scholz, R. and Na, I.K. and Hildebrandt, B. and Riess, H. and Jordan, A. and Schmidt, C.A. and Van Etten, R.A. and Doerken, B. and LeCoutre, P.
Blood Cells Molecules and Diseases 34 (2): 181-185. 1 March 2005

Quantitative RT-PCR of Wilms tumor gene transcripts (WT1) for the molecular monitoring of patients with accelerated phase bcr/abl + CML.
Na, I.K. and Kreuzer, K.A. and Lupberger, J. and Doerken, B. and Coutre, P.
Leukemia Research Reports 29 (3): 343-345. 1 March 2005

2003

Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.
Le Coutre, P. and Kreuzer, K.A. and Na, I.K. and Schwarz, M. and Lupberger, J. and Holdhoff, M. and Baskaynak, G. and Gschaidmeier, H. and Platzbecker, U. and Ehninger, G. and Prejzner, W. and Huhn, D. and Schmidt, C.A.
American Journal of Hematology 73 (4): 249-255. August 2003

Preexistence and evolution of imatinib mesylate-resistant clones in chronic myelogenous leukemia detected by a PNA-based PCR clamping technique.
Kreuzer, K.A. and Le Coutre, P. and Landt, O. and Na, I.K. and Schwarz, M. and Schultheis, K. and Hochhaus, A. and Doerken, B.
Annals of Hematology 82 (5): 284-289. May 2003

2002

Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571.
le Coutre, P. and Kreuzer, K.A. and Na, I.K. and Lupberger, J. and Holdhoff, M. and Appelt, C. and Schwarz, M. and Mueller, C. and Gambacorti-Passerini, C. and Platzbecker, U. and Bonnet, R. and Ehninger, G. and Schmidt, C.A.
Blood Cells Molecules and Diseases 28 (1): 75-85. January 2002

2001

Fluorescent 5'-exonuclease assay for the absolute quantification of Wilms' tumour gene (WT1) mRNA: implications for monitoring human leukaemias.
Kreuzer, K.A. and Saborowski, A. and Lupberger, J. and Appelt, C. and Na, I.K. and le Coutre, P. and Schmidt, C.A.
British Journal of Haematology 114 (2): 313-318. August 2001

This list was generated on Thu Oct 18 02:20:45 2018 CEST.
Open Access
MDC Library